Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting

Go back to Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
(NASDAQ: NRIX) Delayed: 18.65 +1.10 (6.27%)
Previous Close $17.55    52 Week High
Open $17.83    52 Week Low
Day High $18.85    P/E N/A 
Day Low $17.83    EPS
Volume 2,214,257